Iridex (IRIX) Cash from Financing Activities (2011 - 2026)
Iridex (IRIX) posted Cash from Financing Activities of -$38000.0 for Q3 2026, down 3700.0% on a QoQ basis from -$1000.0 in Q2 2026, and down 171.43% year-over-year from $53200.0 in Q3 2025.
Powered by 
Analysis
Iridex (IRIX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Iridex has reported Cash from Financing Activities for 16 years, with the latest figure at -$38000.0 in Q3 2026.
- On a quarterly basis, Cash from Financing Activities fell 171.43% year-over-year to -$38000.0 in Q3 2026; TTM through Jul 2026 was -$100000.0, a 101.16% decrease from a year earlier, with the FY2026 full-year figure at $6.0 million, up 128.94% from the prior year.
- Cash from Financing Activities was -$38000.0 for Q3 2026 at Iridex, down from -$1000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $7.0 million in Q1 2022, with the low at -$218000.0 in Q4 2024.
- Average Cash from Financing Activities over 5 years is $965625.0, with a median of -$19000.0 recorded in 2023.
- The largest YoY upside for Cash from Financing Activities was 11862.5% in 2024 against a maximum downside of 584.44% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$26000.0 in 2022, then jumped by 273.08% to $45000.0 in 2023, then plunged by 584.44% to -$218000.0 in 2024, then surged by 84.4% to -$34000.0 in 2025, then fell by 11.76% to -$38000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$38000.0 (Q3 2026), -$1000.0 (Q2 2026), and -$27000.0 (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | -38,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | -38,000.00 |
| Apr 4, 2026 | -1,000.00 |
| Jan 3, 2026 | -27,000.00 |
| Sep 27, 2025 | -34,000.00 |
| Jun 28, 2025 | -14,000.00 |
| Mar 29, 2025 | 6.04 Mn |
| Dec 28, 2024 | -218,000.00 |
| Sep 28, 2024 | 2.82 Mn |
| Dec 30, 2023 | 45,000.00 |
| Sep 30, 2023 | -24,000.00 |
| Jul 1, 2023 | -63,000.00 |
| Apr 1, 2023 | 37,000.00 |
| Oct 1, 2022 | -26,000.00 |
| Jul 2, 2022 | -53,000.00 |
| Apr 2, 2022 | 6,000.00 |
| Jan 1, 2022 | 7.00 Mn |
| Apr 3, 2021 | 9.89 Mn |
| Sep 26, 2020 | -25,000.00 |
| Jun 27, 2020 | 2.50 Mn |
| Mar 28, 2020 | -2,000.00 |